Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Veterans' surgery outcomes could improve with Team-Based care

NCT ID NCT05037292

Disease control Sponsor: VA Office of Research and Development Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a team of specialists working together can improve outcomes for frail Veterans having elective surgery. About 35,000 Veterans at three VA hospitals will be randomly assigned to usual care or a multidisciplinary board that reviews each case and makes personalized recommendations. The main goal is to see if this approach lowers the risk of death within 180 days after surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

35,015 people

The number who actually took part.

Started

Oct 2021

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a US federal agency other than the NIH.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Chart/Database Review: * Patient must have elective surgery within the intervention period * Surgery must be with a qualifying specialty (general, vascular, orthopedics, cardio-thoracic, urology, neurosurgery, and others \[e.g., Plastics/ENT\]) * Surgery must be at either the VA Palo Alto, VA Houston, or VA Nashville VA Providers: * Service and Section Chief Interviews: * Must be the Surgery Service Line chief (or appointed designee). * Must be Section Chief (or appointed designee) of a qualifying surgical specialty (general, vascular, orthopedics, cardio-thoracic, urology, neurosurgery, and others \[e.g., Plastics/ENT\]). * Must serve at the VA Palo Alto, VA Houston, or VA Nashville. * Focus Groups: * Must be a healthcare provider at VA Palo Alto, VA Houston, or VA Nashville. * Must have planned or prior experience participating in PAUSE Board meetings. * Referral Frequency Interviews: * Must be a member of the surgical team with one of the qualifying surgical specialties (general, vascular, orthopedics, cardio-thoracic, urology, neurosurgery, and others \[e.g., Plastics/ENT\]). * Must be one of the high- or low-referring providers to the PAUSE Board. Exclusion Criteria: Chart/Database Review: -Non-Veteran (USA) VA Providers: -Refusal or inability to participate during site visits.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Frailty are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Frailty

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Frailty

Contacts and locations

Locations

  • Michael E. DeBakey VA Medical Center, Houston, TX

    Houston, Texas, 77030, United States

  • Tennessee Valley Healthcare System Nashville Campus, Nashville, TN

    Nashville, Tennessee, 37212-2637, United States

  • VA Palo Alto Health Care System, Palo Alto, CA

    Palo Alto, California, 94304-1207, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.